The fundamental role of epigenetic events in cancer (original) (raw)

• Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21 (2002).An excellent review of mammalian DNA methylation.
  CAS PubMed Google Scholar
• Takai, D. & Jones, P. A. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl Acad. Sci. USA 99, 3740–3745 (2002).
  CAS PubMed PubMed Central Google Scholar
• Baylin, S. B. & Herman, J. G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16, 168–174 (2000).
  CAS PubMed Google Scholar
• Jones, P. A. & Laird, P. W. Cancer epigenetics comes of age. Nature Genet. 21, 163–167 (1999).
  Article CAS PubMed Google Scholar
• Esteller, M. et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res. 60, 2368–2371 (2000).
  CAS PubMed Google Scholar
• Herman, J. G. et al. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res. 57, 837–841 (1997).
  CAS PubMed Google Scholar
• Burbee, D. G. et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J. Natl Cancer Inst. 93, 691–699 (2001).
  CAS PubMed Google Scholar
• Dammann, R. et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nature Genet. 25, 315–319 (2000).
  CAS PubMed Google Scholar
• Herman, J. G. et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl Acad. Sci. USA 91, 9700–9704 (1994).
  CAS PubMed PubMed Central Google Scholar
• Esteller, M. et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl Cancer Inst. 92, 564–569 (2000).
  CAS PubMed Google Scholar
• Esteller, M. et al. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz–Jeghers syndrome. Oncogene 19, 164–168 (2000).
  CAS PubMed Google Scholar
• Hedenfalk, I. et al. Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344, 539–548 (2001).
  CAS PubMed Google Scholar
• Van't Veer, L. J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536 (2002).
  CAS Google Scholar
• Knudson, A. G. Chasing the cancer demon. Annu. Rev. Genet. 34, 1–19 (2000).
  CAS PubMed Google Scholar
• Myohanen, S. K., Baylin, S. B. & Herman, J. G. Hypermethylation can selectively silence individual p16 ink4A alleles in neoplasia. Cancer Res. 58, 591–593 (1998).
  CAS PubMed Google Scholar
• Grady, W. M. et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nature Genet. 26, 16–17 (2000).
  CAS PubMed Google Scholar
• Esteller, M. et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum. Mol. Genet. 10, 3001–3007 (2001).
  CAS PubMed Google Scholar
• Kane, M. F. et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57, 808–811 (1997).
  CAS PubMed Google Scholar
• Herman, J. G. et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl Acad. Sci. USA 95, 6870–6875 (1998).References 18 and 19 provided an important link between epigenetic and genetic changes in colon cancer. Reference 19 illustrates how demethylation of an aberrantly silenced gene in cancer can restore gene expression and function.
  Article CAS PubMed PubMed Central Google Scholar
• Nakagawa, H. et al. Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res. 61, 6991–6995 (2001).
  CAS PubMed Google Scholar
• Esteller, M. et al. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am. J. Pathol. 155, 1767–1772 (1999).
  CAS PubMed PubMed Central Google Scholar
• Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B. & Herman, J. G. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 59, 793–797 (1999).
  CAS PubMed Google Scholar
• Esteller, M. et al. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res. 61, 4689–4692 (2001).
  CAS PubMed Google Scholar
• Wales, M. M. et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Med. 1, 570–577 (1995).
  CAS PubMed Google Scholar
• Huang, T. H., Perry, M. R. & Laux, D. E. Methylation profiling of CpG islands in human breast cancer cells. Hum. Mol. Genet. 8, 459–470 (1999).
  CAS PubMed Google Scholar
• Toyota, M. et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 59, 2307–2312 (1999).
  CAS PubMed Google Scholar
• Costello, J. F. et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nature Genet. 24, 132–138 (2000).
  CAS PubMed Google Scholar
• Gonzalgo, M. L. et al. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 57, 594–599 (1997).
  CAS PubMed Google Scholar
• Gitan, R. S., Shi, H., Chen, C. M., Yan, P. S. & Huang, T. H. Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res. 12, 158–164 (2002).
  CAS PubMed PubMed Central Google Scholar
• Suzuki, H. et al. A genomic screen for genes upregulated by demethylation and HDAC inhibition in human colorectal cancer. Nature Genet. May 6 [epub ahead of print] 2002.
• Coulondre, C., Miller, J. H., Farabaugh, P. J. & Gilbert, W. Molecular basis of base substitution hotspots in Escherichia coli. Nature 274, 775–780 (1978).
  CAS PubMed Google Scholar
• Rideout, W. M. III, Coetzee, G. A., Olumi, A. F. & Jones, P. A. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 249, 1288–1290 (1990).This paper provides an example of how the base methylcytosine provides an endogenous site of mutagenic potential in the coding region of important genes.
  CAS PubMed Google Scholar
• Pfeifer, G. P., Tang, M. & Denissenko, M. F. Mutation hotspots and DNA methylation. Curr. Top. Microbiol. Immunol. 249, 1–19 (2000).
  CAS PubMed Google Scholar
• Yoon, J. H. et al. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers. Cancer Res. 61, 7110–7117 (2001).
  CAS PubMed Google Scholar
• Magewu, A. N. & Jones, P. A. Ubiquitous and tenacious methylation of the CpG site in codon 248 of the p53 gene may explain its frequent appearance as a mutational hotspot in human cancer. Mol. Cell. Biol. 14, 4225–4232 (1994).
  CAS PubMed PubMed Central Google Scholar
• Feinberg, A. P. & Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301, 89–92 (1983).
  CAS PubMed Google Scholar
• Feinberg, A. P., Gehrke, C. W., Kuo, K. C. & Ehrlich, M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 48, 1159–1161 (1988).These two papers outline the presence of DNA hypomethylation in human tumours.
  CAS PubMed Google Scholar
• Xu, G. L. et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402, 187–191 (1999).
  CAS PubMed Google Scholar
• Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247–257 (1999).An important paper that discusses the function of the mammalian DNMTs in establishing and maintaining DNA methylation patterns.
  CAS PubMed Google Scholar
• Hansen, R. S. et al. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl Acad. Sci. USA 96, 14412–14417 (1999).
  CAS PubMed PubMed Central Google Scholar
• Qu, G. Z., Grundy, P. E., Narayan, A. & Ehrlich, M. Frequent hypomethylation in Wilms tumors of pericentromeric DNA in chromosomes 1 and 16. Cancer Genet. Cytogenet. 109, 34–39 (1999).
  CAS PubMed Google Scholar
• Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L. & Jaenisch, R. DNA hypomethylation leads to elevated mutation rates. Nature 395, 89–93 (1998).
  CAS PubMed Google Scholar
• Chan, M. F. et al. Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells. Mol. Cell. Biol. 21, 7587–7600 (2001).
  CAS PubMed PubMed Central Google Scholar
• Kass, S. U., Landsberger, N. & Wolffe, A. P. DNA methylation directs a time-dependent repression of transcription initiation. Curr. Biol. 7, 157–165 (1997).
  CAS PubMed Google Scholar
• Wutz, A., Rasmussen, T. P. & Jaenisch, R. Chromosomal silencing and localization are mediated by different domains of Xist RNA. Nature Genet. 30, 167–174 (2002).
  CAS PubMed Google Scholar
• Jones, P. A. & Taylor, S. M. Cellular differentiation, cytidine analogs and DNA methylation. Cell 20, 85–93 (1980).This paper was the first to show that 5-azacytidine can induce demethylation of DNA.
  CAS PubMed Google Scholar
• Murzina, N., Verreault, A., Laue, E. & Stillman, B. Heterochromatin dynamics in mouse cells: interaction between chromatin assembly factor 1 and HP1 proteins. Mol. Cell 4, 529–540 (1999).
  CAS PubMed Google Scholar
• Struhl, K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599–606 (1998).
  CAS PubMed Google Scholar
• Taddei, A., Maison, C., Roche, D. & Almouzni, G. Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases. Nature Cell Biol. 3, 114–120 (2001).
  CAS PubMed Google Scholar
• Bird, A. P. & Wolffe, A. P. Methylation-induced repression – belts, braces, and chromatin. Cell 99, 451–454 (1999).
  CAS PubMed Google Scholar
• Jones, P. L. et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genet. 19, 187–191 (1998).
  CAS PubMed Google Scholar
• Ng, H. H. et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nature Genet. 23, 58–61 (1999).
  CAS PubMed Google Scholar
• Wade, P. A. et al. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nature Genet. 23, 62–66 (1999).References 51–53 were the first to link DNA methylation with gene silencing by identifying the chromatin-remodelling proteins with which methylcytosine-binding proteins associate.
  CAS PubMed Google Scholar
• Bell, A. C. & Felsenfeld, G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405, 482–485 (2000).
  CAS PubMed Google Scholar
• Hark, A. T. et al. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405, 486–489 (2000).
  CAS PubMed Google Scholar
• Mikovits, J. A. et al. Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-γ) promoter and subsequent downregulation of IFN-γ production. Mol. Cell. Biol. 18, 5166–5177 (1998).
  CAS PubMed PubMed Central Google Scholar
• Graff, J. R., Herman, J. G., Myohanen, S., Baylin, S. B. & Vertino, P. M. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation. J. Biol. Chem. 272, 22322–22329 (1997).
  CAS PubMed Google Scholar
• Graff, J. R., Gabrielson, E., Fujii, H., Baylin, S. B. & Herman, J. G. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J. Biol. Chem. 275, 2727–2732 (2000).
  CAS PubMed Google Scholar
• Jenuwein, T. & Allis, C. D. Translating the histone code. Science 293, 1074–1080 (2001).An important review of the latest thinking on the histone code, which marks and/or establishes regions of transcriptionally repressive versus transcriptionally active chromatin.
  CAS PubMed Google Scholar
• Bannister, A. J. et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410, 120–124 (2001).
  CAS PubMed Google Scholar
• Nakayama, J., Rice, J. C., Strahl, B. D., Allis, C. D. & Grewal, S. I. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 292, 110–113 (2001).
  CAS PubMed Google Scholar
• Noma, K., Allis, C. D. & Grewal, S. I. Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries. Science 293, 1150–1155 (2001).
  CAS PubMed Google Scholar
• Zhang, Y. & Reinberg, D. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 15, 2343–2360 (2001).
  CAS PubMed Google Scholar
• Tamaru, H. & Selker, E. U. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 414, 277–283 (2001).
  CAS PubMed Google Scholar
• Jackson, J. P., Lindroth, A. M., Cao, X. & Jacobsen, S. E. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature 416, 556–560 (2002).References 64 and 65 provide the exciting concept that a specific site of histone methylation might specify where DNA methylation occurs.
  CAS PubMed Google Scholar
• Cameron, E. E., Bachman, K. E., Myohanen, S., Herman, J. G. & Baylin, S. B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nature Genet. 21, 103–107 (1999).This paper illustrates the synergy between DNA methylation and histone deacetylation in the aberrant silencing of tumour-suppressor genes and the dominant role of DNA methylation.
  CAS PubMed Google Scholar
• Nguyen, C. T., Gonzales, F. A. & Jones, P. A. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res. 29, 4598–4606 (2001).
  CAS PubMed PubMed Central Google Scholar
• Magdinier, F. & Wolffe, A. P. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc. Natl Acad. Sci. USA 98, 4990–4995 (2001).
  CAS PubMed PubMed Central Google Scholar
• El-Osta, A., Kantharidis, P., Zalcberg, J. R. & Wolffe, A. P. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Mol. Cell. Biol. 22, 1844–1857 (2002).
  CAS PubMed PubMed Central Google Scholar
• Robertson, K. D. et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 27, 2291–2298 (1999).
  CAS PubMed PubMed Central Google Scholar
• De Marzo, A. M. et al. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res. 59, 3855–3860 (1999).
  CAS PubMed Google Scholar
• Wu, J. et al. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells. Proc. Natl Acad. Sci. USA 90, 8891–8895 (1993).
  CAS PubMed PubMed Central Google Scholar
• Bakin, A. V. & Curran, T. Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science 283, 387–390 (1999).
  CAS PubMed Google Scholar
• Laird, P. W. et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81, 197–205 (1995).This paper presented a role for DNMT1 in tumorigenesis and the concept that decreasing the action of this enzyme could be a therapeutic goal for treating cancer.
  CAS PubMed Google Scholar
• Fuks, F., Burgers, W. A., Brehm, A., Hughes-Davies, L. & Kouzarides, T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nature Genet. 24, 88–91 (2000).
  CAS PubMed Google Scholar
• Robertson, K. D. et al. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nature Genet. 25, 338–342 (2000).
  CAS PubMed Google Scholar
• Rountree, M. R., Bachman, K. E. & Baylin, S. B. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nature Genet. 25, 269–277 (2000).
  CAS PubMed Google Scholar
• Fuks, F., Burgers, W. A., Godin, N., Kasai, M. & Kouzarides, T. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J. 20, 2536–2544 (2001).
  CAS PubMed PubMed Central Google Scholar
• Bachman, K. E., Rountree, M. R. & Baylin, S. B. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J. Biol. Chem. 276, 32282–32287 (2001).References 75–79 report that mammalian DNMTs probably have additional roles in transcriptional silencing by recruiting histone deacetylases, acting as transcriptional repressors and serving as binding platforms for transcriptional co-repressors.
  CAS PubMed Google Scholar
• Taddei, A., Roche, D., Sibarita, J. B., Turner, B. M. & Almouzni, G. Duplication and maintenance of heterochromatin domains. J. Cell Biol. 147, 1153–1166 (1999).
  CAS PubMed PubMed Central Google Scholar
• Liang, G. et al. Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements. Mol. Cell. Biol. 22, 480–491 (2002).
  CAS PubMed PubMed Central Google Scholar
• Velicescu, M. et al. Cell division is required for de novo methylation of CpG islands in bladder cancer cells. Cancer Res. 62, 2378–2384 (2002).
  CAS PubMed Google Scholar
• Di Croce, L. et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295, 1079–1082 (2002).
  CAS PubMed Google Scholar
• Rhee, I. et al. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature 404, 1003–1007 (2000).
  CAS PubMed Google Scholar
• Rhee, I. et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 416, 552–556 (2002).References 83–85 report that the DNMTs might act cooperatively in maintaining aberrant gene silencing. Reference 85 provides evidence for epigenetics in the silencing of the tumour-suppressor gene CDKN2A.
  CAS PubMed Google Scholar
• Panning, B. & Jaenisch, R. DNA hypomethylation can activate Xist expression and silence X-linked genes. Genes Dev. 10, 1991–2002 (1996).
  CAS PubMed Google Scholar
• Jackson-Grusby, L. et al. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nature Genet. 27, 31–39 (2001).
  CAS PubMed Google Scholar
• Sun, F. L. & Elgin, S. C. Putting boundaries on silence. Cell 99, 459–462 (1999).
  CAS PubMed Google Scholar
• Turker, M. S. & Bestor, T. H. Formation of methylation patterns in the mammalian genome. Mutat. Res. 386, 119–130 (1997).
  CAS PubMed Google Scholar
• Issa, J. P. et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nature Genet. 7, 536–540 (1994).
  CAS PubMed Google Scholar
• Issa, J. P. Aging, DNA methylation and cancer. Crit. Rev. Oncol. Hematol. 32, 31–43 (1999).Papers 90 and 91 discuss a possible link between aberrant DNA methylation, ageing and cancer.
  CAS PubMed Google Scholar
• Cairns, J. Cancer: Science and Society (W. H. Freeman & Co., San Francisco, California, 1978).
  Google Scholar
• Cameron, E. E., Baylin, S. B. & Herman, J. G. p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood 94, 2445–2451 (1999).
  CAS PubMed Google Scholar
• Greller, L. D., Tobin, F. L. & Poste, G. Tumor heterogeneity and progression: conceptual foundations for modeling. Invasion Metastasis 16, 177–208 (1996).
  CAS PubMed Google Scholar
• Fidler, I. J. The biology of cancer metastasis, or 'you cannot fix it if you do not know how it works'. Bioessays 13, 551–554 (1991).
  CAS PubMed Google Scholar
• Nuovo, G. J., Plaia, T. W., Belinsky, S. A., Baylin, S. B. & Herman, J. G. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc. Natl Acad. Sci. USA 96, 12754–12759 (1999).
  CAS PubMed PubMed Central Google Scholar
• Wong, D. J., Foster, S. A., Galloway, D. A. & Reid, B. J. Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest. Mol. Cell. Biol. 19, 5642–5651 (1999).
  CAS PubMed PubMed Central Google Scholar
• Kiyono, T. et al. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84–88 (1998).
  CAS PubMed Google Scholar
• Issa, J. P., Ahuja, N., Toyota, M., Bronner, M. P. & Brentnall, T. A. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 61, 3573–3577 (2001).
  CAS PubMed Google Scholar
• Comijn, J. et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell 7, 1267–1278 (2001).
  CAS PubMed Google Scholar
• Mareel, M., Bracke, M. & Van Roy, F. Cancer metastasis: negative regulation by an invasion-suppressor complex. Cancer Detect. Prev. 19, 451–464 (1995).
  CAS PubMed Google Scholar
• Cihak, A. Biological effects of 5-azacytidine in eukaryotes. Oncology 30, 405–422 (1974).
  CAS PubMed Google Scholar
• Lubbert, M. DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action. Curr. Top. Microbiol. Immunol. 249, 135–164 (2000).
  CAS PubMed Google Scholar
• Lin, X. et al. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Cancer Res. 61, 8611–8616 (2001).
  CAS PubMed Google Scholar
• Wolf, S. F. & Migeon, B. R. Studies of X chromosome DNA methylation in normal human cells. Nature 295, 667–671 (1982).
  CAS PubMed Google Scholar
• Mohandas, T., Sparkes, R. S. & Shapiro, L. J. Reactivation of an inactive X human chromosome: evidence for X inactivation by DNA methylation. Science 211, 393–396 (1981).
  CAS PubMed Google Scholar
• Jaenisch, R., Schnieke, A. & Harbers, K. Treatment of mice with 5-azacytidine efficiently activates silent retroviral genomes in different tissues. Proc. Natl Acad. Sci. USA 82, 1451–1455 (1985).
  CAS PubMed PubMed Central Google Scholar
• Liang, G., Gonzales, F. A., Jones, P. A., Orntoft, T. F. & Thykjaer, T. Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2′-deoxycytidine. Cancer Res. 62, 961–966 (2002).
  CAS PubMed Google Scholar
• Soengas, M. S. et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409, 207–211 (2001).
  CAS PubMed Google Scholar
• Bender, C. M. et al. Roles of cell division and gene transcription in the methylation of CpG islands. Mol. Cell. Biol. 19, 6690–6698 (1999).
  CAS PubMed PubMed Central Google Scholar
• Sidransky, D. Emerging molecular markers of cancer. Nature Rev. Cancer 2, 210–219 (2002).
  CAS Google Scholar
• Esteller, M., Corn, P. G., Baylin, S. B. & Herman, J. G. A gene hypermethylation profile of human cancer. Cancer Res. 61, 3225–3229 (2001).
  CAS PubMed Google Scholar
• Adorjan, P. et al. Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res. 30, e21 (2002).
  PubMed PubMed Central Google Scholar